Prenatal Testing

Juno Hazel Increases Accessiblity of Non-Invasive Prenatal Screening

Juno Diagnostics has announced the launch of Juno Hazel, a non-invasive prenatal screening (NIPS) solution.

Prenatal Testing

Biomarkers Id’d that May Detect Pregnancy Risks Earlier

Researchers have identified biological markers that could improve blood tests of pregnant women to detect risks of pregnancy complications earlier.

Prenatal Testing

Scientists Develop Blood Test to Predict Environmental Harms to Children

The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.

Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia

Jul 5, 2020 | Prenatal Testing

The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.

BillionToOne Has Closed Its Follow-On Series A+ Funding Round of $15 Million

Mar 12, 2020 | Company News, Prenatal Testing

The new funding will be used to support commercial expansion of the company’s Unity prenatal screening test to all US states as well as research and development for future diagnostics.

Thermo Fisher Scientific and NX Prenatal Collaborate to Develop Fetal Health Assays

Jun 11, 2019 | Balances, Mass Spectrometry, Mass Spectrometry Instruments, Mass Spectrometry Reagents & Test Kits, Prenatal Testing, Research

Thermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.

First Customizable Noninvasive Prenatal Test for Single-Gene Disorders

May 13, 2019 | Prenatal Testing, Standards

The test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.

Prenatal Screening Identifies More Couples at Risk for Birth Defects

May 13, 2019 | Prenatal Testing, Research

The Foresight carrier screen identified 45% more couples at risk for having a child with cystic fibrosis than current guideline-based testing.

Next-Generation Multiplexing

Mar 27, 2019 | Microscopy, Prenatal Testing, Software

A novel multiplexing platform called ‘high definition polymerase chain reaction’ brings together widely used, low-cost chemistries and qPCR instrumentation with proprietary data science algorithms to enable streamlined multiplex test development and very affordable test deliverables.

Parsortix Harvests Fetal Cells from the Blood of Pregnant Women

Dec 20, 2018 | Prenatal Testing, Research

The Parsortix system offers the potential to extend NIPT to a wide range of conditions not feasible with existing techniques.

Study Validates Biomarker for Aneuploidy and Adverse Pregnancy Outcomes

Sep 24, 2018 | Prenatal Testing, Research

Statisticians used data from more than a million Panorama tests to devise an algorithm that computes a fetal fraction-based risk score for pregnancy.

August/September Product News

Aug 30, 2018 | Prenatal Testing, Software

This month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.

Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies

Jul 16, 2018 | Hematology & Serology, Prenatal Testing, Transfusion & Transplantation Tests

A noninvasive prenatal test for zygosity in twin pregnancies enables obstetricians to triage patients and avoid both overtreatment and undertreatment.

Qiagen, Natera Partner to Develop NGS Assays

Apr 26, 2018 | Prenatal Testing, Software

For use on Qiagen’s next-generation sequencing system, the cell-free DNA assays will enable access to genetic testing, including prenatal screening, in hospitals and laboratories globally.

Illumina, Harvard Pilgrim Expand Access to Next-Generation Sequencing for NIPT

Mar 14, 2018 | Prenatal Testing, Womens Health

Illumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.

BD Launches Blood Collection Tube for Cancer, Noninvasive Prenatal Testing Applications

Mar 14, 2018 | Prenatal Testing, Tubes

The plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology, and was designed to ensure accurate and reproducible results in molecular diagnostic testing applications using circulating cell-free DNA.